Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population
Hypertension

About this trial
This is an interventional treatment trial for Hypertension
Eligibility Criteria
Inclusion criteria:
- Systolic blood pressure < 180 mmHg
- 90 mmHg ≤ Diastolic blood pressure < 110 mmHg
Exclusion criteria:
- Pregnancy or lactation. Women of child bearing potential (not post-menopausal) should be using a reliable contraceptive method
- Known or suspected secondary hypertension (e.g., coarctation of aorta, renovascular stenosis, etc.)
- Presence of clinically significant ventricular or supraventricular arrhythmias, or second or third degree atrioventricular block, or sick sinus syndrome
- ALAT[SGPT]>2 times of upper limit,
- ASAT[SGOT]>2 times of upper limit
- Patients with known renal disease
- Serum potassium > normal upper limit
- Uncontroled BD(FBG>10mmol/L or PBG>12.22mmol/L)
- Patients treated with tricyclic antidepressants
- Clinical hematological disease.
- Patients with a history of irbesartan, or hydrochlorothiazide sensitivity defined as irbesartan, or hydrochlorothiazide discontinuation due to medically significant adverse effects.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Sites / Locations
- Sanofi aventis administrative office
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
1
2
4 weeks of one tablet Irbesartan 150mg / Hydrochlorothiazide 12.5mg followed by: If DBP<85mmHg: 4 weeks of one tablet of Irbesartan 150mg / Hydrochlorothiazide 12.5mg If DBP≥85mmHg: 4 weeks of one tablet of Irbesartan 150mg / Hydrochlorothiazide 12.5mg + one tablet of Irbesartan 150mg
2 weeks of one tablet Irbesartan 150mg / Hydrochlorothiazide 12.5mg followed by 2 weeks of one tablet Irbesartan 150mg / Hydrochlorothiazide 12.5mg + one tablet Irbesartan 150mg followed by: If DBP<85mmHg: 4 weeks of of one tablet Irbesartan 150mg / Hydrochlorothiazide 12.5mg + one tablet Irbesartan 150mg If DBP≥85mmHg: 4 weeks of two tablets Irbesartan 150mg / Hydrochlorothiazide 12.5mg